NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses.
about
Efflux-mediated drug resistance in bacteria: an updateCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicSingle-molecule sequencing reveals the molecular basis of multidrug-resistance in ST772 methicillin-resistant Staphylococcus aureus.Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementationPhosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus.Genes contributing to Staphylococcus aureus fitness in abscess- and infection-related ecologies.LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureusCold shock induces qnrA expression in Shewanella algaeStaphylococcus aureus gene expression in a rat model of infective endocarditis.Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA).Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin statusNative efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skinImplication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacinMultidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensReduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA.Biochemistry of bacterial multidrug efflux pumps.Structure elucidation and biological activity of antibacterial compound from Micromonospora auratinigra, a soil Actinomycetes.Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.Lysine and Threonine Biosynthesis from Aspartate Contributes to Staphylococcus aureus Growth in Calf Serum.Role of the Tet38 Efflux Pump in Staphylococcus aureus Internalization and Survival in Epithelial Cells.Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus.Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.Mechanisms of drug resistance: quinolone resistance.Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo.RND multidrug efflux pumps: what are they good for?oqxAB encoding a multidrug efflux pump in human clinical isolates of EnterobacteriaceaeAssociation of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems.Regulation of expression of abcA and its response to environmental conditions.Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm.Multidrug Efflux Pumps in Staphylococcus aureus: an Update.Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.Efflux Transporter of Siderophore Staphyloferrin A in Staphylococcus aureus Contributes to Bacterial Fitness in Abscesses and Epithelial Cells.Antibiotic resistance in Staphylococcus aureus. Current status and future prospects.Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.
P2860
Q24609407-29BC1ADB-EC31-40AE-9516-7E9A2601A259Q24614464-417DBA9E-7708-45E1-9E78-C4CD07B38DF7Q30650682-CD69F5BA-35F0-4102-97D7-D5A633F3D8AEQ33355620-81110A0A-C77E-4F4B-AE7D-8B6C9C628594Q33826193-8B2A9DE3-2720-4AE6-B78C-2DD01BBB3844Q34237938-7416A21C-3AA6-4BD4-83F0-FBAE8FFDC15EQ34309539-4097ACCF-93A8-4573-A23A-D0CECE5904C3Q34483578-5258C366-3F9C-4355-BCC7-BA8DAD5E1901Q34491802-AC7397A8-0B97-45EC-BF7B-A178B764F19FQ34645896-1723E6B0-1BF2-4FB4-9415-45D7E18817D0Q34792962-2525ABA7-736A-4F3F-92C2-1E531DC34198Q34924567-463EB48F-0652-404D-9178-FD8E64756F51Q35054553-18D6CAC8-3260-48D1-8417-575A5BF279DDQ35065822-60C32DB7-003F-4107-B93D-2D924D54145AQ35131669-BA28E150-816A-468D-980A-562FB044EEA4Q35826704-A4D351B3-0376-4BB3-B8B8-92F2B88E0162Q35933945-F49472D7-9571-4775-BC72-E45BEF6F8A3DQ36074428-8C893900-019E-4B47-B62A-5CC5F828505EQ36090275-3CE8A4CD-A644-41EF-83E1-9A9E6464A38AQ36103390-83436CB8-FDD9-4558-AB55-FEA32CD55420Q36137964-C32D5CCE-8962-4359-A3AA-186FCBEAC90AQ36138054-60FD4C1D-3BDB-4E7A-AFC7-5303B66B7276Q36154055-99A1937E-3002-46F2-A142-CD0E9F70791EQ36225422-3135011B-EF85-4D0A-B34A-780687FD3E23Q36397135-33342ED7-CA29-43E4-AEE5-BD30C5AE1711Q36586658-9C41EEF9-9693-4CB0-BC7B-883F5997083CQ37274700-2FA70674-DCD0-442D-BA04-195313391749Q37286906-6957EDB9-0568-4B6C-AE46-4F97C786740EQ37385024-4D70229B-0E2A-4243-ACA8-DFE0FBBA6793Q37389801-C1303AFD-9F3F-4C14-86CE-CD34D1CDF6DBQ37713199-64A32989-4F59-4369-8A34-02C479C35527Q38079116-E763CB26-DA1D-44E8-90D8-72D4783584B7Q38097430-176BCCDE-06C7-4717-A9FE-11D243076A1EQ38686020-11ADA269-96E1-4239-8CD0-C67A22940C7BQ38701802-B51CAAD7-A4D4-43DA-B9E4-38142A0EBC27Q38728885-2869679F-29E5-4889-8AC2-A42C2B33A504Q38906198-7F398B0A-6C6F-4FA6-A455-188C2ACEA07AQ39010675-E48AAA95-5BCA-4C6A-BBA0-EA2E10FD7820Q39185482-94604388-1EEB-4BEB-8EFE-FABA9BEF775FQ39660010-5AC1471D-9905-4637-BA6A-CDFDCD6FE795
P2860
NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
NorB, an efflux pump in Staphy ...... acterial fitness in abscesses.
@en
type
label
NorB, an efflux pump in Staphy ...... acterial fitness in abscesses.
@en
prefLabel
NorB, an efflux pump in Staphy ...... acterial fitness in abscesses.
@en
P2093
P2860
P356
P1476
NorB, an efflux pump in Staphy ...... bacterial fitness in abscesses
@en
P2093
David C Hooper
Yanpeng Ding
Yoshikuni Onodera
P2860
P304
P356
10.1128/JB.00655-08
P407
P50
P577
2008-08-22T00:00:00Z